Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 62, Suchdauer: 2.34s

1
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

von Schwartz, Gregory G. ; Gabriel Steg, P.h. ; Bhatt, Deepak L. ; et al.

In Journal of the American College of Cardiology 3 August 2021 78(5):421-433
- View full text via DOI
Merkliste

2
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

von Schwartz, Gregory G. ; Steg, Ph. Gabriel ; Bhatt, Deepak L. ; et al.

In The Lancet Diabetes & Endocrinology August 2019 7(8):618-628
- View full text via DOI
Merkliste

3
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

von Schwartz, G. G. ; Steg, P. G. ; Szarek, M. ; et al.

Schlagworte: 03 Good Health and Well-being; 03 Salud y bienestar
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

4
Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

von Goodman, Shaun G. ; Aylward, Philip E. ; Szarek, Michael ; et al.

Schlagworte: alirocumab; cholesterol; coronary artery bypass graft; lipids; PCSK9; 03 Good Health and Well-being; 03 Salud y bienestar
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

5
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

von Bittner, Vera A. ; Szarek, Michael ; Aylward, Philip E. ; et al.

Schlagworte: acute coronary syndromes; alirocumab; low-density lipoprotein cholesterol; major adverse cardiovascular events; proprotein convertase subtilisin/kexin type 9 inhibition; 03 Good Health and Well-being; 03 Salud y bienestar
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

6
Fracture fixation in the operative management of hip fractures (FAITH): an international, multicentre, randomised controlled trial

von Nauth, Aaron ; Creek, Aaron T. ; Zellar, Abby ; et al.

In The Lancet 15-21 April 2017 389(10078):1519-1527
- View full text via DOI
Merkliste

7
Risk categorization using New American College of Cardiology/American Heart Association guidelines for cholesterol management and its relation to alirocumab treatment following acute coronary syndromes

von Roe, Matthew T. ; Li, Qian H. ; Bhatt, Deepak L. ; et al.

0009-7322 ; Circulation

Schlagworte: Human medicine
- View full text via BASE
Merkliste

8
Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial

von Jukema, J. Wouter ; Szarek, Michael ; Zijlstra, Laurien E. ; et al.

0735-1097 ; Journal of the American College of Cardiology

Schlagworte: Human medicine
- View full text via BASE
Merkliste

9
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

von White, Harvey D. ; Steg, Ph. Gabriel ; Harrington, Robert A. ; et al.

European heart journal 40(33), 2801-2809 (2019). doi:10.1093/eurheartj/ehz299 special issue: "Focus Issue on LIPIDS"

Schlagworte: info:eu-repo/classification/ddc/610
- View full text via BASE
Merkliste

10
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

von Szarek, Michael ; White, Harvey D. ; Schwartz, Gregory G. ; et al.

ISSN:0735-1097 ; ISSN:1558-3597 ; Journal Of The American College Of Cardiology, vol. 73 (4), (387-396.

Schlagworte: Science & Technology; Life Sciences & Biomedicine; Cardiac & Cardiovascular Systems; Cardiovascular System & Cardiology; acute coronary syndrome; alirocumab; total events; ACUTE CORONARY SYNDROMES; STATIN THERAPY; REDUCTION; Aged; Antibodies; Monoclonal; Humanized; Drug Therapy; Combination; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; ODYSSEY OUTCOMES Committees and Investigators; 1102 Cardiorespiratory Medicine and Haematology; 1117 Public Health and Health Services; Cardiovascular System & Hematology; 3201 Cardiovascular medicine and haematology
- View full text via BASE
Merkliste

11
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab ; Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.

von Hagström, Emil ; Steg, Philippe Gabriel ; Szarek, Michael ; et al.

ISSN: 0009-7322.

Schlagworte: PCSK9 inhibitors; heart disease risk factors; LDL; cholesterol; apolipoproteins B; acute coronary syndrome; MESH: Acute Coronary Syndrome; MESH: Antibodies; Monoclonal; Humanized; MESH: Hydroxymethylglutaryl-CoA Reductase Inhibitors; MESH: Risk Factors; MESH: Treatment Outcome; MESH: Anticholesteremic Agents; MESH: Apolipoproteins B; MESH: Atherosclerosis; MESH: Cardiovascular Diseases; MESH: Cholesterol; MESH: Heart Disease Risk Factors; MESH: Humans; [SDV]Life Sciences [q-bio]
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

12
Fixation using alternative implants for the treatment of hip fractures (FAITH): design and rationale for a multi-centre randomized trial comparing sliding hip screws and cancellous screws on revision surgery rates and quality of life in the treatment of femoral neck fractures

von McCormack, Robert ; Apostle, Kelly ; Moon, Raely ; et al.

BMC musculoskeletal disorders 15, 219 (2014). doi:10.1186/1471-2474-15-219

Schlagworte: DE
- View full text via BASE
Merkliste

13
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment

von Mcclanahan, Mark ; Dempsey, Michael ; Colhoun, Helen ; et al.

ISSN: 0149-5992.

Schlagworte: MESH: Antibodies; Monoclonal; Humanized; MESH: Anticholesteremic Agents; MESH: Diabetes Mellitus; Type 2; MESH: Double-Blind Method; MESH: Humans; MESH: Lipoprotein(a); MESH: Proprotein Convertase 9; MESH: Treatment Outcome; [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism; [SDV.SP.MED]Life Sciences [q-bio]/Pharmaceutical sciences/Medication; [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

14
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

von Bittner, Vera A. ; Szarek, Michael ; Aylward, Philip E. ; et al.

0735-1097 ; Journal of the American College of Cardiology

Schlagworte: Human medicine
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

15
Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

von Steg, Philippe Gabriel ; Szarek, Michael ; Bhatt, Deepak L. ; et al.

0009-7322 ; Circulation

Schlagworte: Human medicine
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

16
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

von Ray, Kausik K. ; Colhoun, Helen M. ; Szarek, Michael ; et al.

2213-8587 ; Lancet diabetes & endocrinology

Schlagworte: Human medicine
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

17
Alirocumab reduces total hospitalizations and increases days alive and out of hospital in the ODYSSEY OUTCOMES trial

von Szarek, Michael ; Steg, Ph. Gabriel ; DiCenso, Dina ; et al.

1941-7713 ; Circulation : cardiovascular quality and outcomes

Schlagworte: Human medicine
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

18
Dieses Ergebnis aus Social Sciences Citation Index kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

19
Femoral Neck Shortening After Hip Fracture Fixation Is Associated With Inferior Hip Function : Results From the FAITH Trial

von Felton, Jessica ; Slobogean, Gerard P. ; Bhandari, Mohit ; et al.

Journal of orthopaedic trauma : JOT 33(10), 487-496 (2019). doi:10.1097/BOT.0000000000001551

Schlagworte: info:eu-repo/classification/ddc/610
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

20
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

21
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes

von Roe, Matthew T ; Li, Qian H ; Bhatt, Deepak L ; et al.

Elements

Schlagworte: Science & Technology; Life Sciences & Biomedicine; Cardiac & Cardiovascular Systems; Peripheral Vascular Disease; Cardiovascular System & Cardiology; alirocumab; acute coronary syndrome; dyslipidemias; guideline; CARDIOVASCULAR OUTCOMES; STATIN THERAPY; ADDING EZETIMIBE; BENEFIT; EVENTS; PCSK9
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

22
Alirocumab and cardiovascular outcomes after acute coronary syndrome

von Schwartz, G. G. ; Steg, P. G. ; Szarek, M. ; et al.

0028-4793 ; The New England journal of medicine

Schlagworte: Human medicine
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

23
Factors Associated with Revision Surgery after Internal Fixation of Hip Fractures

von Sprague, S. (Sheila) ; Schemitsch, E.H. (Emil H.) ; Swiontkowski, M.F. (Marc ) ; et al.

Schlagworte: cancellous screws; femoral neck fracture; internal fixation; revision surgery; sliding hip screw; info:eu-repo/semantics/other
- Zum Volltext über OAIster
Merkliste

24
Fracture fixation in the operative management of hip fractures (FAITH): an international, multicentre, randomised controlled trial

von Nauth, A. (Aaron) ; Creek, A.T. (Aaron T.) ; Zellar, A. (Abby) ; et al.

Schlagworte: info:eu-repo/semantics/article
- Zum Volltext über OAIster
Merkliste

25
Fixation using alternative implants for the treatment of hip fractures (FAITH): design and rationale for a multi-centre randomized trial comparing sliding hip screws and cancellous screws.

von McCormack, Robert ; Apostle, Kelly ; Boyer, Dory ; et al.

Schlagworte: Clinical sciences
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag